Alabama
CNS trials open to children and teens in Alabama
16 CNS studies open to children and teens are recruiting participants at sites in 4 cities across Alabama as of November 18, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Browse Alabama by city
Cities with the most studies recruiting right now.
Birmingham
7 studies recruiting.
Dothan
5 studies recruiting.
Every Alabama city with a recruiting study
By research area: Depression (4), Migraine (4), ADHD (3), Epilepsy (3), Schizophrenia (2).
Birmingham (7), Dothan (5), Huntsville (4), Saraland (3).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
ADHD: recently updated in Alabama
Basic details from each study's public record (the 12 most recently updated of 16). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
- Phase 3
- Ages 6 to 11
- All sexes
- Sponsor
- Axsome Therapeutics, Inc.
- Recruiting in
- Dothan
- Registry record
- NCT07717879 · updated
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
- Phase 3
- Ages 12 to 17
- All sexes
- Sponsor
- Axsome Therapeutics, Inc.
- Recruiting in
- Dothan
- Registry record
- NCT07717892 · updated
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
- Phase 4
- From 48 months, up to 69 months
- All sexes
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Recruiting in
- Saraland
- Registry record
- NCT04781140 · updated
Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in Alabama on ClinicalTrials.gov.
Depression: recently updated in Alabama
Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus
- No phase
- Ages 12 to 22
- All sexes
- Sponsor
- Michigan State University
- Recruiting in
- Birmingham
- Registry record
- NCT06232304 · updated
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
- Phase 3
- Ages 10 to 17
- All sexes
- Sponsor
- Intra-Cellular Therapies, Inc.
- Recruiting in
- Dothan
- Registry record
- NCT06372964 · updated
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
- Phase 3
- Ages 12 to 17
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Recruiting in
- Birmingham
- Registry record
- NCT07227454 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Alabama on ClinicalTrials.gov.
Epilepsy: recently updated in Alabama
Retraining and Control Therapy (ReACT): Sense of Control and Symptom Expectations as Targets of a Treatment for PNES
- No phase
- Ages 11 to 18
- All sexes
- Sponsor
- University of Alabama at Birmingham
- Recruiting in
- Birmingham
- Registry record
- NCT05096273 · updated
Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Alabama on ClinicalTrials.gov.
Migraine: recently updated in Alabama
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Phase 3
- Ages 12 to 17
- All sexes
- Sponsor
- AbbVie
- Recruiting in
- Huntsville
- Registry record
- NCT06810505 · updated
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- AbbVie
- Recruiting in
- Huntsville · Saraland
- Registry record
- NCT05711394 · updated
Responding With Evidence and Access for Childhood Headaches
- No phase
- Ages 10 to 17
- All sexes
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Recruiting in
- Birmingham
- Registry record
- NCT05889624 · updated
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- AbbVie
- Recruiting in
- Huntsville · Saraland
- Registry record
- NCT05125302 · updated
Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Alabama on ClinicalTrials.gov.
Schizophrenia: recently updated in Alabama
Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
- Phase 4
- Ages 12 to 17
- All sexes
- Sponsor
- Vanda Pharmaceuticals
- Recruiting in
- Dothan
- Registry record
- NCT05648591 · updated
Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in Alabama on ClinicalTrials.gov.
Ask about studies in Alabama
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that set an upper age limit, with at least half of the ages they accept under 18, as each study is coded in the registry.
CNS Pediatric Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections